Alternating therapeutic plasma exchange (TPE) with double plasma molecular adsorption system (DPMAS) for the treatment of fulminant hepatic failure (FHF)

Alternating therapeutic plasma exchange with double plasma molecular adsorption system can rapidly remove bilirubin and ammonia and supplement the essential substance from the blood, which could be used as an effective treatment for fulminant hepatic failure.

Detalles Bibliográficos
Autores principales: Lei, Yan, Liang, Yuling, Zhang, Xuemei, Wang, Xiaohua, Zhang, Yu, Chan, Yuk Ming, Tang, Chun, Zheng, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667290/
https://www.ncbi.nlm.nih.gov/pubmed/34938567
http://dx.doi.org/10.1002/ccr3.5220
_version_ 1784614364735602688
author Lei, Yan
Liang, Yuling
Zhang, Xuemei
Wang, Xiaohua
Zhang, Yu
Chan, Yuk Ming
Tang, Chun
Zheng, Zhihua
author_facet Lei, Yan
Liang, Yuling
Zhang, Xuemei
Wang, Xiaohua
Zhang, Yu
Chan, Yuk Ming
Tang, Chun
Zheng, Zhihua
author_sort Lei, Yan
collection PubMed
description Alternating therapeutic plasma exchange with double plasma molecular adsorption system can rapidly remove bilirubin and ammonia and supplement the essential substance from the blood, which could be used as an effective treatment for fulminant hepatic failure.
format Online
Article
Text
id pubmed-8667290
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86672902021-12-21 Alternating therapeutic plasma exchange (TPE) with double plasma molecular adsorption system (DPMAS) for the treatment of fulminant hepatic failure (FHF) Lei, Yan Liang, Yuling Zhang, Xuemei Wang, Xiaohua Zhang, Yu Chan, Yuk Ming Tang, Chun Zheng, Zhihua Clin Case Rep Case Report Alternating therapeutic plasma exchange with double plasma molecular adsorption system can rapidly remove bilirubin and ammonia and supplement the essential substance from the blood, which could be used as an effective treatment for fulminant hepatic failure. John Wiley and Sons Inc. 2021-12-13 /pmc/articles/PMC8667290/ /pubmed/34938567 http://dx.doi.org/10.1002/ccr3.5220 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Lei, Yan
Liang, Yuling
Zhang, Xuemei
Wang, Xiaohua
Zhang, Yu
Chan, Yuk Ming
Tang, Chun
Zheng, Zhihua
Alternating therapeutic plasma exchange (TPE) with double plasma molecular adsorption system (DPMAS) for the treatment of fulminant hepatic failure (FHF)
title Alternating therapeutic plasma exchange (TPE) with double plasma molecular adsorption system (DPMAS) for the treatment of fulminant hepatic failure (FHF)
title_full Alternating therapeutic plasma exchange (TPE) with double plasma molecular adsorption system (DPMAS) for the treatment of fulminant hepatic failure (FHF)
title_fullStr Alternating therapeutic plasma exchange (TPE) with double plasma molecular adsorption system (DPMAS) for the treatment of fulminant hepatic failure (FHF)
title_full_unstemmed Alternating therapeutic plasma exchange (TPE) with double plasma molecular adsorption system (DPMAS) for the treatment of fulminant hepatic failure (FHF)
title_short Alternating therapeutic plasma exchange (TPE) with double plasma molecular adsorption system (DPMAS) for the treatment of fulminant hepatic failure (FHF)
title_sort alternating therapeutic plasma exchange (tpe) with double plasma molecular adsorption system (dpmas) for the treatment of fulminant hepatic failure (fhf)
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667290/
https://www.ncbi.nlm.nih.gov/pubmed/34938567
http://dx.doi.org/10.1002/ccr3.5220
work_keys_str_mv AT leiyan alternatingtherapeuticplasmaexchangetpewithdoubleplasmamolecularadsorptionsystemdpmasforthetreatmentoffulminanthepaticfailurefhf
AT liangyuling alternatingtherapeuticplasmaexchangetpewithdoubleplasmamolecularadsorptionsystemdpmasforthetreatmentoffulminanthepaticfailurefhf
AT zhangxuemei alternatingtherapeuticplasmaexchangetpewithdoubleplasmamolecularadsorptionsystemdpmasforthetreatmentoffulminanthepaticfailurefhf
AT wangxiaohua alternatingtherapeuticplasmaexchangetpewithdoubleplasmamolecularadsorptionsystemdpmasforthetreatmentoffulminanthepaticfailurefhf
AT zhangyu alternatingtherapeuticplasmaexchangetpewithdoubleplasmamolecularadsorptionsystemdpmasforthetreatmentoffulminanthepaticfailurefhf
AT chanyukming alternatingtherapeuticplasmaexchangetpewithdoubleplasmamolecularadsorptionsystemdpmasforthetreatmentoffulminanthepaticfailurefhf
AT tangchun alternatingtherapeuticplasmaexchangetpewithdoubleplasmamolecularadsorptionsystemdpmasforthetreatmentoffulminanthepaticfailurefhf
AT zhengzhihua alternatingtherapeuticplasmaexchangetpewithdoubleplasmamolecularadsorptionsystemdpmasforthetreatmentoffulminanthepaticfailurefhf

Ejemplares similares